Aurinia Pharmaceuticals Inc’s latest rating changes from various analysts
Aurinia Pharmaceuticals Inc’s recently made public that its Chief Commercial Officer Habig Scott Michael unloaded Company’s shares for reported $96902.0
Aurinia Pharmaceuticals Inc’s recently made public that its Chief Commercial Officer Habig Scott Michael unloaded Company’s shares for reported $96902.0
In a filing, Aurinia Pharmaceuticals Inc revealed its Chief Commercial Officer Habig Scott Michael unloaded Company’s shares for reported $96902.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Inc’s recently made public that its Chief Commercial Officer Habig Scott Michael unloaded Company’s shares for reported $96902.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recently made public that its Chief Commercial Officer Habig Scott Michael unloaded Company’s shares for reported $96902.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Aurinia Pharmaceuticals Inc revealed its Chief Commercial Officer Habig Scott Michael unloaded Company’s shares for reported $96902.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Aurinia Pharmaceuticals
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.